Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • JC Virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient.

    jean elcheikh
    e2012043
    2012-06-20
    https://doi.org/10.4084/mjhid.2012.043
    1061
    PDF: 783
    HTML: 10910
  • Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome

    alessandro andriani, Laura Marchetti, Fabio Rossi, Silvia Raja, Maria Antonietta Perretti, Umberto Recine
    e2024030
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.030
    574
    PDF: 999
    HTML: 78
  • SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival

    Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Aikaterini Pentidou, Spanoudakis Emmanouil
    e2021006
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.006
    1947
    PDF: 775
    HTML: 194
  • CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

    Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone
    e2024010
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.010
    3687
    PDF: 3032
    HTML: 182
  • REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

    Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst
    e2021012
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.012
    1471
    PDF: 557
    HTML: 167
  • CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA

    guangliang Chen, Dou-dou Li, Sufen Sufen, Shiyu Jiang, Qunling Zhang, jia jin, Zuguang Xia, Yizhen Liu, Xiaojian Liu, Yanzhe Zhu, Yu Chen, Lingli Gu, Xiaonan Hong, Junning Cao, Rong Tao, Fangfang Lv
    e2022066
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.066
    858
    PDF: 589
    HTML: 215
  • PRE AND POST-MONOCLONAL INFUSION NEUTRALIZING ACTIVITY IN A SUBGROUP OF PATIENTS TREATED IN THE PRESENCE OF TWO SARS-COV-2 DOMINANT VARIANT OF CONCERN (VOCS) AND AN ONGOING VACCINATION. OVERALL CLINICAL EFFICACY OF TWO MONOCLONAL ANTIBODIES ASSOCIATION IN UMBRIA

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Anna Gidari, Lisa Malincarne, Sara Benedetti , Alessandra Lanzi, Sabrina Bastianelli, Sara Pierucci, Chiara busti, Daniela Francisci
    e2022050
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.050
    1529
    PDF: 497
    HTML: 203
  • NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

    Alessandro Corso, Silvia Mangiacavalli
    e2017053
    2017-08-18
    https://doi.org/10.4084/mjhid.2017.053
    3133
    PDF: 1677
    HTML: 1067
  • BEHÇET’S SYNDROME AND THROMBOSIS

    Emire Seyahi, Sebahattin Yurdakul
    e2011026
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.026
    2750
    PDF: 1594
    HTML: 16947
  • Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia

    Marco Andreani, Manuela Testi, Pietro Sodani, Maria Troiano, Andrea Di Luzio, Giuseppe Testa, Michela Falco, Elvira Poggi, Javid Gaziev, Antonina Piazza
    e2017020
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.020
    2847
    PDF: 923
    HTML: 518
  • CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

    Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda
    e2019067
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.067
    2766
    PDF: 1777
    HTML: 726
  • PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

    Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli
    e2019015
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.015
    1748
    PDF: 947
    HTML: 286
  • CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS

    Nilüfer Yeşilot Barlas, Gülşen Akman-Demir, Sara Zarko Bahar
    e2011044
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.044
    2196
    PDF: 729
    HTML: 1239
  • CLINICAL USEFULNESS OF BROCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF PULMONARY INFILTRATES IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES AND STEM CELL TRANSPLANTATION

    Laura Jorge, Diego Torres, Agustín Languasco, Pablo Rodriguez, Pablo Bonvehí, Elena Temporiti, Silvia Relloso, Cristina Videla, Fabián Herrera
    e2020025
    2020-05-01
    https://doi.org/10.4084/mjhid.2020.025
    8011
    PDF: 731
    HTML: 199
  • FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL

    Muhammad Imran Hasan Khan, Eram Anwar, Adnan Agha, Noha Saleh, Ehsan Ullah, Imran Ali Syed, Arsalan Raja
    e2013014
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.014
    2345
    HTML: 9374
    DOCX: 972
    Tables Dengue: 190
  • T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections

    Muhamad R. Abdel Hameed, Sherein G. Elgendy, Mohamed A El-Mokhtar, Douaa Sayed, Samar M. Mansour, Abeer M. Darwish
    e2022022
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.022
    1685
    PDF: 641
    HTML: 311
  • APLASTIC ANEMIA AND VIRAL HEPATITIS

    Laura Cudillo
    e2009026
    https://doi.org/10.4084/mjhid.2009.026
    1212
    PDF: 512
    HTML: 22989
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3536
    PDF: 1359
    HTML: 166
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    4641
    PDF: 1908
    HTML: 8270
  • THE RELATIONSHIP BETWEEN PERIODONTAL DISEASE (PD) AND CARDIOVASCULAR DISEASE (CVD).

    Maurizio Trevisan, Joan Dorn
    e2010030
    2010-10-01
    https://doi.org/10.4084/mjhid.2010.030
    1764
    PDF: 1032
    HTML: 1423
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1319
    PDF: 579
    HTML: 217
  • MALARIA IN CHILDREN

    Richard-Fabian Schumacher, Elena Spinelli
    e2012073
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.073
    5190
    PDF: 2618
    HTML: 7308
  • THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML

    Dr. Palmieri, Ilaria Del Principe, Dr. Maurillo, Prof. Venditti, Francesco Buccisano
    e2023051
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.051
    1515
    PDF: 772
    HTML: 136
  • LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

    Andrea Riccardo Filippi
    e2016041
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.041
    3633
    PDF: 1044
    HTML: 2257
    Figure 1: 194
  • COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Stefan Hohaus, Luciana Teofili, Mario Balducci, Stefania Manfrida, Angelo Pompucci, Francesco D'Alo', Giuseppina Massini, Luigi Maria Larocca, Roberto Marra, Sergio Storti
    e2009020
    2009-12-14
    https://doi.org/10.4084/mjhid.2009.020
    2029
    PDF: 515
    HTML: 2272
  • ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication

    Maria Chiara Tisi, Giuseppe Ausoni, Maria Gabriella Vita, Tommaso Tartaglione, Mario Balducci, Luca Laurenti, Patrizia Chiusolo, Stefan Hohaus, Simona Sica
    e2015025
    2015-02-17
    https://doi.org/10.4084/mjhid.2015.025
    2312
    PDF: 958
    HTML: 1627
    Fig 1: 165
    Tab I: 190
    Cover Letter: 180
  • INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA

    Sutatta Supatharawanich, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Bunchoo Pongtanakul, Sasima Tongsai, Phakatip Sinlapamongkolkul, Popchai Ngamskulrungroj, Wanatpreeya Phongsamart, Kleebsabai Sanpakit , Jassada Buaboonnam
    e2021039
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.039
    2527
    PDF: 722
    HTML: 194
  • CONTRIBUTION OF MARITAL DISTANCE TO COMMUNITY INBREEDING, HOMOZYGOSIS, AND REPRODUCTIVE WASTAGE FOR RECESSIVELY INHERITED GENETIC DISORDERS IN MADHYA PRADESH, INDIA

    R S Balgir
    e2013063
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.063
    1166
    PDF: 939
    HTML: 1356
    Untitled: 73
  • PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD

    Beatrice Autino, Yolanda Corbett, Francesco Castelli, Donatella Taramelli
    e2012061
    2012-10-04
    https://doi.org/10.4084/mjhid.2012.061
    4312
    PDF: 1859
    HTML: 17705
  • SICKLE CELL DISEASE AND PREGNANCY

    Dipty Jain, Pooja Lodha, Roshan Colah, Prachi Atmapoojya, Prachi Atmapoojya
    e2019040
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.040
    5772
    PDF: 3565
    HTML: 414
  • Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis

    Saveria Capria, Federico De Angelis, Giuseppe Gentile, Silvia Maria Trisolini, Simonetta Brocchieri, Martina Canichella, Patrizia Chiusolo, Alessandra Micozzi, Robin Foà, Giovanna Meloni
    e2013048
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.048
    1467
    PDF: 647
    HTML: 1875
  • LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

    Fabian Herrera
    e2024039
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.039
    1236
    PDF: 976
    HTML: 105
  • PREVALENCE OF HEPATITIS C AMONG EGYPTIAN CHILDREN WITH SICKLE CELL DISEASE AND THE ROLE OF IL28B GENE POLYMORPHISMS IN SPONTANEOUS VIRAL CLEARANCE

    Somaia Mohammed Mousa, Mona Kamal El-Ghamrawy, Heba Gouda, Mervat Khorshied, Dina Ahmed, Hala Shiba
    e2016007
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.007
    3775
    PDF: 771
    HTML: 2444
  • CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

    Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi
    e2009030
    https://doi.org/10.4084/mjhid.2009.030
    1224
    PDF: 586
    HTML: 3051
  • the EARLY TREATMENT WITH BAMLANIVIMAB ALONE DOES NOT PREVENT COVID-19 HOSPITALIZATION AND ITS POST-ACUTE SEQUELAE. A REAL EXPERIENCE IN UMBRIA, ITALY.

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Laura Martinelli Martinelli, lisa malincarne, Martina Savoia, Anna Laura Spinelli, Daniela Francisci
    e2021061
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.061
    1140
    PDF: 371
    HTML: 166
  • THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS

    Alessia Bari, Luigi Marcheselli, Raffaella Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Sacchi
    e2011065
    2011-12-20
    https://doi.org/10.4084/mjhid.2011.065
    2497
    PDF: 700
    HTML: 2281
  • THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT

    Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson
    e2010009
    2010-05-03
    https://doi.org/10.4084/mjhid.2010.009
    1022
    PDF: 676
    HTML: 598
  • EVALUATION OF ORAL DOXYCYCLINE, AZITHROMYCIN, OR SEQUENTIAL DOXYCYCLINE-AZITHROMYCIN TREATMENT FOR SCRUB TYPHUS-

    Hanchen Liu, Weizhen Wang, Yuqing Dong
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.020
    511
    PDF: 284
    HTML: 66
  • EXPRESSION AND CLINICAL CORRELATION OF PD-1/PD-L1 AND VE1(BRAFP.V600E) IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS

    sneha tandon, Sheila Weitzman , Brooklyn Joyce, Bryan Maguire, Derek Stephens, James Whitlock, Cynthia Hawkins , Bo-Yee Ngan, Oussama Abla
    e2023035
    2023-04-27
    https://doi.org/10.4084/MJHID.2023.035
    960
    PDF: 853
    HTML: 225
  • CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children

    Giuseppe Lassandro, Valentina  Palladino, Anna Amoruso, Viviana Palmieri, Giovanna Russo, Paola Giordano
    e2020042
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.042
    1340
    PDF: 901
    HTML: 281
  • EXTRAMEDULLARY DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA: TWO-IN-ONE DISEASE

    Francesco Albano, Giorgina Specchia
    e2011066
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.066
    2234
    PDF: 809
    HTML: 2809
  • FLT3 INTERNAL TANDEM DUPLICATION AND D835 MUTATIONS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS CLINICAL SIGNIFICANCE

    Ghaleb Elyamany, Mohamed Awad, Omar Alsuhaibani, Kamal Fadalla, Omer Al Sharif, Mohammad Al Shahrani, Fahad Alabbas, Abdulaziz Al-Abulaaly
    e2014038
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.038
    1755
    PDF: 945
    HTML: 7159
  • INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.

    Malgorzata Mikulska, Matteo Bassetti, Sandra Ratto, Claudio Viscoli
    e2011007
    2011-01-25
    https://doi.org/10.4084/mjhid.2011.007
    2199
    PDF: 910
    HTML: 11096
  • RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

    Julie Schanz, Friederike Braulke, Detlef Haase
    e2015034
    2015-04-23
    https://doi.org/10.4084/mjhid.2015.034
    3619
    PDF: 1597
    HTML: 11461
    Figures Haase: 173
  • ANALYSIS OF PROGNOSTIC RISK FACTORS OF BLOODSTREAM INFECTIONS IN BEIJING COMMUNITIES: A RETROSPECTIVE STUDY FROM 2015 TO 2019

    Yan Liu, Beichen Cui, Chunmei Pi, Xiaohong Yu, Zhiwei Liu, Xiang Li, Liping Ma, Cong Wang
    e2021060
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.060
    776
    PDF: 303
    HTML: 105
  • BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA

    Alzbeta Zavrelova, Jakub Radocha, Pavla Paterova, Pavel Zak, Benjamin Visek, Martin Sima
    e2023001
    2022-12-31
    https://doi.org/10.4084/MJHID.2023.001
    1129
    PDF: 1064
    HTML: 413
  • A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

    Elena Amabile, Matteo Totaro, Luca Cappelli, Clara Minotti, Alessandra Micozzi
    e2024013
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.013
    854
    PDF: 1136
    HTML: 132
  • NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014

    Abraham Tareq Yacoub, Jayasree Krishnan, Ileana M. Acevedo, Joseph Halliday, John Norman Greene
    e2015030
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.030
    2013
    PDF: 960
    HTML: 4045
    Cover Letter: 204
    Figure 1: 201
    Figure 2: 209
    Table 1: 185
  • EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE

    Luana Fianchi, Martina Quattrone, Marianna Criscuolo, Silvia Bellesi, Giulia Dragonetti, Alessio Maria Edoardo Maraglino, Matteo Bonanni, Patrizia Chiusolo, Simona Sica, Livio Pagano
    Page e2021030
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.030
    2280
    PDF: 804
    HTML: 293
  • SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

    Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2024020
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.020
    998
    PDF: 1196
    HTML: 87
151 - 200 of 500 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy